Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Paracervical Block With Combined Ketorolac and Lidocaine on Perceived Pain in Osmotic Dilator Placement for Abortion, a Randomized Controlled Trial

NCT07487246 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT07487246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07487246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Paracervical Block With Combined Ketorolac and Lidocaine on Perceived Pain in Osmotic Dilator Placement for Abortion, a Randomized Controlled Trial
Lead sponsor
Rush University Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
June 29, 2026
Completion date
April 30, 2027
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion, dilation and evacuation, pain management, second trimester abortion